Perspective Therapeutics (CATX) Equity Average (2011 - 2026)
Perspective Therapeutics recorded quarterly Equity Average of $277.2 million in Q1 2026, up 23.42% quarter-over-quarter from $224.6 million in Q4 2025, and down 3.62% year-over-year from $287.7 million in Q1 2025.
Perspective Therapeutics' Equity Average history runs 15 years deep, the most recent figure standing at $277.2 million for Q1 2026.
- In Q1 2026, Equity Average fell 3.62% year-over-year to $277.2 million; the TTM figure through Mar 2026 stood at $277.2 million (down 3.62% YoY), while the FY2025 annual figure was $248.8 million, up 36.04% from the prior year.
- Equity Average came in at $277.2 million for Q1 2026 at Perspective Therapeutics, up from $224.6 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $334.7 million in Q3 2024 to a low of $56.2 million in Q4 2022.
- A 5-year average of $178.4 million and a median of $152.5 million in 2024 frame the typical range for Equity Average.
- Across the five-year window, Equity Average jumped 255.93% in 2024 and dropped 27.44% in 2025, its largest moves.
- Perspective Therapeutics' Equity Average stood at $56.2 million in 2022, then jumped by 54.84% to $87.0 million in 2023, then surged by 255.93% to $309.6 million in 2024, then fell by 27.44% to $224.6 million in 2025, then climbed by 23.42% to $277.2 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $277.2 million, $224.6 million, and $254.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 277.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 277.23 Mn |
| Dec 31, 2025 | 224.62 Mn |
| Sep 30, 2025 | 253.95 Mn |
| Jun 30, 2025 | 275.17 Mn |
| Mar 31, 2025 | 287.66 Mn |
| Dec 31, 2024 | 309.57 Mn |
| Sep 30, 2024 | 334.73 Mn |
| Jun 30, 2024 | 285.44 Mn |
| Mar 31, 2024 | 152.54 Mn |
| Dec 31, 2023 | 86.97 Mn |
| Sep 30, 2023 | 103.71 Mn |
| Jun 30, 2023 | 113.34 Mn |
| Mar 31, 2023 | 86.34 Mn |
| Dec 31, 2022 | 56.17 Mn |
| Sep 30, 2022 | 59.49 Mn |
| Jun 30, 2022 | 62.24 Mn |
| Mar 31, 2022 | 63.80 Mn |
| Dec 31, 2021 | 65.08 Mn |
| Sep 30, 2021 | 66.58 Mn |
| Jun 30, 2021 | 67.75 Mn |
| Mar 31, 2021 | 40.44 Mn |
| Dec 31, 2020 | 8.93 Mn |
| Sep 30, 2020 | 5.41 Mn |
| Jun 30, 2020 | 5.77 Mn |
| Mar 31, 2020 | 5.98 Mn |
| Dec 31, 2019 | 6.55 Mn |
| Sep 30, 2019 | 7.32 Mn |
| Jun 30, 2019 | 8.15 Mn |
| Mar 31, 2019 | 9.14 Mn |
| Dec 31, 2018 | 10.39 Mn |
| Sep 30, 2018 | 8.07 Mn |
| Jun 30, 2018 | 5.82 Mn |
| Mar 31, 2018 | 7.24 Mn |
| Dec 31, 2017 | 8.51 Mn |
| Sep 30, 2017 | 9.87 Mn |
| Jun 30, 2017 | 11.42 Mn |
| Mar 31, 2017 | 12.91 Mn |
| Dec 31, 2016 | 14.27 Mn |
| Sep 30, 2016 | 15.69 Mn |
| Jun 30, 2016 | 16.96 Mn |
| Mar 31, 2016 | 18.04 Mn |
| Jun 30, 2014 | 24.30 Mn |
| Mar 31, 2014 | 15.57 Mn |
| Dec 31, 2013 | 6.95 Mn |
| Sep 30, 2013 | 6.39 Mn |
| Jun 30, 2013 | 5.85 Mn |
| Mar 31, 2013 | 6.68 Mn |
| Dec 31, 2012 | 7.59 Mn |
| Sep 30, 2012 | 6.99 Mn |
| Jun 30, 2012 | 5.98 Mn |
| Mar 31, 2012 | 6.41 Mn |
| Dec 31, 2011 | 6.05 Mn |
| Sep 30, 2011 | 5.94 Mn |